C/O DENNIS M. LANFEAR, REDWOOD CITY, CA
Other Events
Reports Second Quarter 2025 Financial Results and Provides Business Update
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Shareholder votes
Completes Strategic Transformation, Focusing Exclusively on Innovative Cancer Therapeutics
Reports First Quarter 2025 Financial Results and Provides Business Update
Annual Report to Security Holders
Changes in Board, Management or Compensation
Q2
Q1
FY 2024
Q3
FY 2023
SC TO-I
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
S-4
Additional Proxy Materials
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
PREM14A
Correspondence
Submission Upload